As of 2026-10-04, the Relative Valuation of Solid Biosciences Inc (SLDB) is (43.33) USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.85 USD, the upside of Solid Biosciences Inc based on Relative Valuation is -732.6%.
The range of the Relative Valuation is (37.44) - (52.38) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.8x - 24.9x | 21.4x |
| Forward P/E multiples | 14.7x - 25.0x | 19.8x |
| Fair Price | (37.44) - (52.38) | (43.33) |
| Upside | -646.6% - -864.7% | -732.6% |
| Date | P/E |
| 2026-09-29 | -3.40 |
| 2026-09-28 | -3.46 |
| 2026-09-25 | -3.47 |
| 2026-09-24 | -3.56 |
| 2026-09-23 | -3.81 |
| 2026-09-22 | -4.24 |
| 2026-09-21 | -4.06 |
| 2026-09-18 | -4.24 |
| 2026-09-17 | -4.22 |
| 2026-09-16 | -4.15 |
| 2026-09-15 | -3.98 |
| 2026-09-14 | -4.15 |
| 2026-09-11 | -4.14 |
| 2026-09-10 | -4.31 |
| 2026-09-09 | -4.54 |
| 2026-09-08 | -4.72 |
| 2026-09-04 | -4.87 |
| 2026-09-03 | -4.95 |
| 2026-09-02 | -4.89 |
| 2026-09-01 | -4.70 |
| 2026-08-31 | -4.55 |
| 2026-08-28 | -4.64 |
| 2026-08-27 | -4.82 |
| 2026-08-26 | -4.62 |
| 2026-08-25 | -4.70 |
| 2026-08-24 | -4.35 |
| 2026-08-21 | -4.42 |
| 2026-08-20 | -4.33 |
| 2026-08-19 | -4.63 |
| 2026-08-18 | -4.32 |
| 2026-08-17 | -4.33 |
| 2026-08-14 | -4.37 |
| 2026-08-13 | -4.32 |
| 2026-08-12 | -4.31 |
| 2026-08-11 | -4.21 |
| 2026-08-10 | -4.07 |
| 2026-08-07 | -3.99 |
| 2026-08-06 | -4.14 |
| 2026-08-05 | -4.15 |
| 2026-08-04 | -4.10 |
| 2026-08-03 | -3.81 |
| 2026-07-31 | -3.83 |
| 2026-07-30 | -4.04 |
| 2026-07-29 | -3.82 |
| 2026-07-28 | -3.79 |
| 2026-07-27 | -3.75 |
| 2026-07-24 | -3.72 |
| 2026-07-23 | -3.79 |
| 2026-07-22 | -3.85 |
| 2026-07-21 | -4.02 |